| Dawson S Brown, MD | |
|
4409 Nw Anderson Hill Rd, Silverdale, WA 98383-6807 | |
| (360) 698-6630 | |
| (360) 698-7002 |
| Full Name | Dawson S Brown |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 17 Years |
| Location | 4409 Nw Anderson Hill Rd, Silverdale, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588867394 | NPI | - | NPPES |
| 1588867394 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD60365964 (Washington) | Primary |
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | MD60365964 (Washington) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harrison Medical Center | Bremerton, WA | Hospital |
| Jefferson Healthcare | Port townsend, WA | Hospital |
| Olympic Medical Center | Port angeles, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Medical Group | 0547173866 | 1115 |
News Archive
Combining two promising approaches to diagnosing and treating cancer, a multidisciplinary research team at the University of Michigan has created a targeted multifunctional polymer nanoparticle that successfully images and kills brain tumors in laboratory animals.
Taking the triglyceride-lowering medication icosapent ethyl cut the risk of stroke by an additional 36% in people at increased risk of cardiovascular disease who already have their bad cholesterol levels under control using statin medications, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2021.
BioMarin Pharmaceutical Inc. announced today that it has acquired ZyStor Therapeutics, Inc. (ZyStor), a privately-held biotechnology company developing enzyme replacement therapies (ERT) for the treatment of lysosomal storage disorders. ZyStor's lead product candidate is ZC-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for Pompe disease.
Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.
› Verified 5 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
Combining two promising approaches to diagnosing and treating cancer, a multidisciplinary research team at the University of Michigan has created a targeted multifunctional polymer nanoparticle that successfully images and kills brain tumors in laboratory animals.
Taking the triglyceride-lowering medication icosapent ethyl cut the risk of stroke by an additional 36% in people at increased risk of cardiovascular disease who already have their bad cholesterol levels under control using statin medications, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2021.
BioMarin Pharmaceutical Inc. announced today that it has acquired ZyStor Therapeutics, Inc. (ZyStor), a privately-held biotechnology company developing enzyme replacement therapies (ERT) for the treatment of lysosomal storage disorders. ZyStor's lead product candidate is ZC-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for Pompe disease.
Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dawson S Brown, MD Po Box 450, Silverdale, WA 98383-0450 Ph: (360) 698-6630 | Dawson S Brown, MD 4409 Nw Anderson Hill Rd, Silverdale, WA 98383-6807 Ph: (360) 698-6630 |
News Archive
Combining two promising approaches to diagnosing and treating cancer, a multidisciplinary research team at the University of Michigan has created a targeted multifunctional polymer nanoparticle that successfully images and kills brain tumors in laboratory animals.
Taking the triglyceride-lowering medication icosapent ethyl cut the risk of stroke by an additional 36% in people at increased risk of cardiovascular disease who already have their bad cholesterol levels under control using statin medications, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2021.
BioMarin Pharmaceutical Inc. announced today that it has acquired ZyStor Therapeutics, Inc. (ZyStor), a privately-held biotechnology company developing enzyme replacement therapies (ERT) for the treatment of lysosomal storage disorders. ZyStor's lead product candidate is ZC-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for Pompe disease.
Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.
› Verified 5 days ago
Omar Abdul-hadi, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4409 Nw Anderson Hill Rd, Silverdale, WA 98383 Phone: 360-698-6630 Fax: 360-698-7002 | |
Kenneth R Koskella, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 4409 Nw Anderson Hill Rd, Silverdale, WA 98383 Phone: 360-698-6630 Fax: 360-698-7002 | |
Dr. Stacee M Kessinger, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4409 Nw Anderson Hill Rd, Silverdale, WA 98383 Phone: 360-698-6630 | |
Brian P Wicks, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2200 Nw Myhre Rd, Silverdale, WA 98383 Phone: 360-830-1100 | |
Marijke Julia Devos, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2200 Nw Myhre Rd, Silverdale, WA 98383 Phone: 360-830-1600 Fax: 360-830-1385 | |
Bradley J. Watters, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4409 Nw Anderson Hill Rd, Silverdale, WA 98383 Phone: 360-698-6630 Fax: 360-698-7002 | |
Thomas C Wilder, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 10452 Silverdale Way Nw, Silverdale, WA 98383 Phone: 360-307-7300 Fax: 360-307-7366 |